The global intravenous infusion pump market size is calculated at USD 6.72 billion in 2025 and is forecasted to reach around USD 13.80 billion by 2034, accelerating at a CAGR of 7.03% from 2025 to 2034. The North America market size surpassed USD 3.11 billion in 2024 and is expanding at a CAGR of 8.30% during the forecast period. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Intravenous Infusion Pump Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Intravenous Infusion Pump Market Revenue and Volume, By Product Type
8.1.1 Volumetric Infusion Pumps
8.1.1.1. Market Revenue and Volume Forecast
8.1.2. Insulin Infusion Pumps
8.1.2.1. Market Revenue and Volume Forecast
8.1.3. Syringe Infusion Pumps
8.1.3.1. Market Revenue and Volume Forecast
8.1.4. Enteral Infusion Pumps
8.1.4.1. Market Revenue and Volume Forecast
8.1.5. Ambulatory Infusion Pumps
8.1.5.1. Market Revenue and Volume Forecast
8.1.6. Patient Controlled Analgesia (PCA)
8.1.6.1. Market Revenue and Volume Forecast
8.1.7. Implantable Infusion Pumps
8.1.7.1. Market Revenue and Volume Forecast
8.1.8. Others
8.1.8.1. Market Revenue and Volume Forecast
9.1. Intravenous Infusion Pump Market Revenue and Volume, By Disease Indication
9.1.1. Chemotherapy
9.1.1.1. Market Revenue and Volume Forecast
9.1.2. Diabetes
9.1.2.1. Market Revenue and Volume Forecast
9.1.3. Gastroenterology
9.1.3.1. Market Revenue and Volume Forecast
9.1.4. Analgesia/Pain Management
9.1.4.1. Market Revenue and Volume Forecast
9.1.5. Pediatrics/Neonatology
9.1.5.1. Market Revenue and Volume Forecast
9.1.6. Hematology
9.1.6.1. Market Revenue and Volume Forecast
9.1.7. Others
9.1.7.1. Market Revenue and Volume Forecast
10.1. North America
10.1.1. Market Revenue and Volume Forecast, By Product Type
10.1.2. Market Revenue and Volume Forecast, By Disease Indication
10.1.3. U.S.
10.1.3.1. Market Revenue and Volume Forecast, By Product Type
10.1.3.2. Market Revenue and Volume Forecast, By Disease Indication
10.1.4. Rest of North America
10.1.4.1. Market Revenue and Volume Forecast, By Product Type
10.1.4.2. Market Revenue and Volume Forecast, By Disease Indication
10.2. Europe
10.2.1. Market Revenue and Volume Forecast, By Product Type
10.2.2. Market Revenue and Volume Forecast, By Disease Indication
10.2.3. UK
10.2.3.1. Market Revenue and Volume Forecast, By Product Type
10.2.3.2. Market Revenue and Volume Forecast, By Disease Indication
10.2.4. Germany
10.2.4.1. Market Revenue and Volume Forecast, By Product Type
10.2.4.2. Market Revenue and Volume Forecast, By Disease Indication
10.2.5. France
10.2.5.1. Market Revenue and Volume Forecast, By Product Type
10.2.5.2. Market Revenue and Volume Forecast, By Disease Indication
10.2.6. Rest of Europe
10.2.6.1. Market Revenue and Volume Forecast, By Product Type
10.2.6.2. Market Revenue and Volume Forecast, By Disease Indication
10.3. APAC
10.3.1. Market Revenue and Volume Forecast, By Product Type
10.3.2. Market Revenue and Volume Forecast, By Disease Indication
10.3.3. India
10.3.3.1. Market Revenue and Volume Forecast, By Product Type
10.3.3.2. Market Revenue and Volume Forecast, By Disease Indication
10.3.4. China
10.3.4.1. Market Revenue and Volume Forecast, By Product Type
10.3.4.2. Market Revenue and Volume Forecast, By Disease Indication
10.3.5. Japan
10.3.5.1. Market Revenue and Volume Forecast, By Product Type
10.3.5.2. Market Revenue and Volume Forecast, By Disease Indication
10.3.6. Rest of APAC
10.3.6.1. Market Revenue and Volume Forecast, By Product Type
10.3.6.2. Market Revenue and Volume Forecast, By Disease Indication
10.4. MEA
10.4.1. Market Revenue and Volume Forecast, By Product Type
10.4.2. Market Revenue and Volume Forecast, By Disease Indication
10.4.3. GCC
10.4.3.1. Market Revenue and Volume Forecast, By Product Type
10.4.3.2. Market Revenue and Volume Forecast, By Disease Indication
10.4.4. North Africa
10.4.4.1. Market Revenue and Volume Forecast, By Product Type
10.4.4.2. Market Revenue and Volume Forecast, By Disease Indication
10.4.5. South Africa
10.4.5.1. Market Revenue and Volume Forecast, By Product Type
10.4.5.2. Market Revenue and Volume Forecast, By Disease Indication
10.4.6. Rest of MEA
10.4.6.1. Market Revenue and Volume Forecast, By Product Type
10.4.6.2. Market Revenue and Volume Forecast, By Disease Indication
10.5. Latin America
10.5.1. Market Revenue and Volume Forecast, By Product Type
10.5.2. Market Revenue and Volume Forecast, By Disease Indication
10.5.3. Brazil
10.5.3.1. Market Revenue and Volume Forecast, By Product Type
10.5.3.2. Market Revenue and Volume Forecast, By Disease Indication
10.5.4. Rest of LATAM
10.5.4.1. Market Revenue and Volume Forecast, By Product Type
10.5.4.2. Market Revenue and Volume Forecast, By Disease Indication
11.1. Arcomed
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. B. Braun Melsungen AG
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. Baxter
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. BD
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. Recent Initiatives
11.5. Boston Scientific Corporation
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. CODAN Companies
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
11.7. Fresenius Kabi AG
11.7.1. Company Overview
11.7.2. Product Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives
11.8. ICU Medical, Inc. (Smiths Medical)
11.8.1. Company Overview
11.8.2. Product Offerings
11.8.3. Financial Performance
11.8.4. Recent Initiatives
11.9. IRadimed Corporation
11.9.1. Company Overview
11.9.2. Product Offerings
11.9.3. Financial Performance
11.9.4. Recent Initiatives
11.10. Micrel Medical Devices SA
11.10.1. Company Overview
11.10.2. Product Offerings
11.10.3. Financial Performance
11.10.4. Recent Initiatives
12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions
13.1. About Us
13.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
Plan your call and get expert insights!
Schedule a Meeting
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample